ImmunityBio (IBRX) Return on Assets [ROA] (2015 - 2026)
ImmunityBio's Return on Assets [ROA] was -155.66% in Q2 2026, down 51.62 percentage points from -104.04% a year earlier and down 6.84 percentage points from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Return on Assets [ROA] (2015 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at ImmunityBio came in at -79.44%, up 13.78 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of +43.57 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -93.23% in FY2024 (+41.49 pp), -134.71% in FY2023 (-34.31 pp), -100.41% in FY2022 (+0.96 pp) and -101.36% in FY2021 (+21.65 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] in data going back to Q3 2015.
- Compared with a year earlier, Return on Assets [ROA] was higher in five of the last eight quarters, with an average year-over-year change of +9.59 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2025 (a gain of 69.64 percentage points); the worst was Q2 2026 (a drop of 51.62 percentage points).
- Per Business Quant data, IBRX's Return on Assets [ROA] in the three quarters before Q2 2026 was -148.82% (Q1 2026), -68.86% (Q4 2025) and -75.72% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | ImmunityBio | 10.83 Bn | 9.59 Bn | 50.94 Mn | -155.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -155.66% |
| Mar 31, 2026 | -148.82% |
| Dec 31, 2025 | -68.86% |
| Sep 30, 2025 | -75.72% |
| Jun 30, 2025 | -104.04% |
| Mar 31, 2025 | -119.17% |
| Dec 31, 2024 | -110.67% |
| Sep 30, 2024 | -145.35% |
| Jun 30, 2024 | -141.48% |
| Mar 31, 2024 | -132.89% |
| Dec 31, 2023 | -124.64% |
| Sep 30, 2023 | -126.79% |
| Jun 30, 2023 | -149.47% |
| Mar 31, 2023 | -122.11% |
| Dec 31, 2022 | -116.68% |
| Sep 30, 2022 | -119.45% |
| Jun 30, 2022 | -106.83% |
| Mar 31, 2022 | -86.75% |
| Dec 31, 2021 | -102.39% |
| Sep 30, 2021 | -141.89% |
API Access
ImmunityBio Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();